Clinical Registries Need Streamlining To Reap Benefits, Mussallem Tells Congress
This article was originally published in The Gray Sheet
Executive Summary
Clinical registries can yield useful information on patient outcomes that can support approval, reimbursement and care decisions but the benefits of registries need to be balanced against their costs, Edwards Lifesciences CEO Michael Mussalem told a House Energy and Commerce subcommittee July 22.